Screener
Acadia Pharmaceuticals ACAD Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accrued liabilities | 46,088 | 21,350 |
| Operating lease liabilities | (4,032) | (1,418) |
| Long-term liabilities | (3,829) | 10,492 |
| Net cash provided by operating activities | 134,762 | 84,279 |
| Cash flows from investing activities | ||
| Purchases of investment securities | (108,447) | (330,398) |
| Maturity of investment securities | 176,500 | 262,190 |
| Payment of milestone and contingent payments in connection with asset acquisition | — | (98,838) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's operating cash flow?
- Acadia Pharmaceuticals (ACAD) reported operating cash flow of $100.78M in Q2 2026.
- How has Acadia Pharmaceuticals's operating cash flow changed year-over-year?
- Acadia Pharmaceuticals's operating cash flow increased by 57.6% year-over-year, from $63.96M to $100.78M.
- What is the long-term trend for Acadia Pharmaceuticals's operating cash flow?
- Over 3 years (2021 to 2024), Acadia Pharmaceuticals's operating cash flow has grown at a 7.9% compound annual growth rate (CAGR), from -$125.66M to $157.72M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Acadia Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude